A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
NRG Oncology
Neonc Technologies, Inc.
Gustave Roussy, Cancer Campus, Grand Paris
Mayo Clinic
Cancer Research UK
St. Jude Children's Research Hospital
AC Camargo Cancer Center
University of California, San Francisco
Chinese PLA General Hospital
Stanford University